scispace - formally typeset
C

Calogero Iacono

Researcher at University of Verona

Publications -  133
Citations -  5324

Calogero Iacono is an academic researcher from University of Verona. The author has contributed to research in topics: Pancreatectomy & Pancreas. The author has an hindex of 37, co-authored 131 publications receiving 4718 citations.

Papers
More filters
Journal ArticleDOI

Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors.

TL;DR: The clinicopathological features of 56 patients with mucinous cystic tumors of the pancreas were studied and it was concluded that the biologic behavior of MCTs is predictable on the basis of the extent of invasion.
Journal Article

Pancreatic adenocarcinomas frequently show p53 gene mutations

TL;DR: The data suggest that p53 mutation is one of the genetic defects that may have a role in the pathogenesis of a proportion of pancreatic cancers.
Journal ArticleDOI

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

TL;DR: It is identified that the MF + PI type tumors were significantly associated with negative prognostic factors, such as the involvement of extrahepatic bile ducts, the presence of lymph nodes metastases, the Presence of macroscopic vascular invasion, and positive resection margins were significant related to survival.
Journal ArticleDOI

Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables

TL;DR: Although univariate analysis showed that Ki-67, PCNA, mitotic and PgRP indexes, stage, immunoreactivity for hormones other than insulin, diameter, and nonfunctioning type of tumor were statistically correlated to survival, Cox's regression method let only Ki- 67 index emerge as an independent predictor of survival using a cutoff value of 5% in both FT and NFT.
Journal ArticleDOI

How much remnant is enough in liver resection

TL;DR: The aim of this review is to identify the limits for a safe liver resection in patients with normal liver and injured liver (cirrhosis, cholestasis, steatosis and post-chemotherapy liver injury) and to investigate the different risk factors related to the occurrence of PHLF.